Condensed Statements of Cash Flows (Unaudited) - USD ($)	7 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2024
Cash Flows from Operating Activities:
Net income	$ 3,681,499	$ 7,474,229
Adjustments to reconcile net income to net cash used in operating activities:
Formation costs paid by Sponsor in exchange for issuance of Class B ordinary shares	5,845
Dividend income earned on marketable securities held in Trust Account	(4,329,480)	(10,167,128)
Changes in operating assets and liabilities:
Prepaid expenses	(30,723)	(19,919)
Prepaid insurance	(335,917)	162,166
Accounts payable and accrued expenses	197,693	1,791,188
Net cash used in operating activities	(811,083)	(759,464)
Cash Flows from Investing Activities:
Investment of cash into Trust Account	(251,250,000)
Net cash provided by (used in) investing activities	(251,250,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid	245,600,000
Proceeds from sale of private placements warrants	7,650,000
Proceeds from convertible promissory note – related party		700,000
Repayment of promissory note – related party	(179,665)
Payment of offering costs	(671,664)	(75,000)
Net cash provided by (used in) financing activities	252,398,671	625,000
Net Change in Cash	337,588	(134,464)
Cash – Beginning of period		275,665
Cash – End of period	337,588	141,201
Supplemental disclosure of cash flow information:
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares	11,000
Prepaid services contributed by Sponsor in exchange for issuance of Class B ordinary shares	8,607
Deferred offering costs paid through promissory note – related party	179,213
Accretion of Class A ordinary shares to redemption value	25,850,159	10,167,128
Deferred underwriting fee payable	13,100,000
Forfeiture of Founder Shares	$ 8